arrow
Back
D

David T. Rubin

university of chicago medicine inflammatory bowel disease center

87H-index
1.5KPaper Count
3.4WCitation Count
Published Papers 526
Publication Date
IOIBD: the International Organization for the Study of Inflammatory Bowel Disease
err2026-08-02
err0
PREAI
errIris Dotan; Marla C. Dubinsky; Corey A. Siegel; James Lindsay; Dermot McGovern; Matthieu Allez; Pär Myrelid; James Lewis; Bruce E. Sands; Laurent Peyrin-Biroulet; Silvio Danese; Vineet Ahuja; Gilaad G. Kaplan; Marischka Konings; Richard Gearry; Siew C. Ng; Vipul Jairath; Fernando Magro; Mark S. Silverberg; Dan Turner; Maria T. Abreu; Ailsa Hart; Axel Dignass; David T. Rubin;
errShare
errSave
Global Roll-Out and Continued Multi-Site Validation of the Artificial Intelligence Histology Instrument for Qualitative Assessment of Histopathology in Ulcerative Colitis
err2026-07-30
err0
errOAAI
errLaurent Peyrin-Biroulet; Olga Kubassova; Jon Himoff; Christopher R. Weber; Shashi Adsul; Marcelo Freire; Bader E. Hussaini; Luc Biedermann; Viktor H. Koelzer; Brian Bressler; Wei Xiong; Jan H. Niess; Matthias S. Matter; Uri Kopylov; Iris Barshack; Chen Mayer; Fernando Magro; Fatima Carneiro; Nitsan Maharshak; Ariel Greenberg; David T. Rubin
errShare
errSave
Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments
err2026-07-28
err0
errOAAI
errDavid T Rubin, MD; Stefan Schreiber, MD; Laurent Peyrin-Biroulet, MD; Silvio Danese, MD, PhD; Milena A Gianfrancesco, PhD; Arif Soonasra, PharmD; Sarah Sidhu, MD; Ivana Vranic, MD; Ahmed Shelbaya, MD, MPH; David Gruben, PhD; Yuqin Wei, MS; Kevin L Winthrop, MD, MPH; Jeffrey R Curtis, MD, MS, MPH; Miguel D Regueiro, MD; Marla C Dubinsky, MD
errShare
errSave
The efficacy and safety of etrasimod as a first-line advanced therapy for ulcerative colitis: prespecified and post hoc subgroup data from the ELEVATE UC clinical program
err2026-07-27
err0
PREAI
errDavid T. Rubin; Charlie W. Lees; Filip Baert; Maria Kudela; Abhishek Bhattacharjee; Krisztina Lazin; Martina Goetsch; Arcangelo M. Abbatemarco; Karolina Wosik; John K. Marshall
errShare
errSave
Curcumin-QingDai Combination for Active Ulcerative Colitis: A Cost-Effectiveness Analysis
err2026-06-01
err0
PREAI
errYanai, Henit; Choi, David; Ben-Horin, Shomron; Salomon, Nir; Loebstein, Ronen; Leshno, Moshe; Rubin, David T.
errShare
errSave
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus
err2026-05-01
err0
PREAI
errPauline Wils; Vipul Jairath; Bruce E Sands; Axel Dignass; Fernando Magro; David T Rubin; Iris Dotan; Walter Reinisch; Parambir Dulai; Richard Gearry; Christopher Ma; Millie Long; Alessandro Armuzzi; Taku Kobayashi; Dan Turner; Sophie Vieujean; Bram Verstockt; Ailsa Hart; Silvio Danese; Laurent Peyrin-Biroulet
errShare
errSave
Long-term Safety of Upadacitinib in Patients with Inflammatory Bowel Disease: Integrated Analysis of Phase 2/3 Studies
err2026-02-27
err0
errOAAI
errRemo Panaccione; Julián Panés; Laurent Peyrin-Biroulet; Jean-Frédéric Colombel; James O. Lindsay; Filip Baert; Raja Atreya; Séverine Vermeire; Toshimitsu Fujii; Elena Dubcenco; Justin Klaff; Benjamin Duncan; Smitha Suravaram; Irina Fish; Ana P. Lacerda; Ramona Vladea; Sharanya Ford; Saajan Shah; Samuel I. Anyanwu; David T. Rubin
errShare
errSave
DESI Strong Lens Foundry. I. HST Observations and Modeling with GIGA-Lens
err2026-02-03
err0
errOAAI
errXiaosheng Huang; Saul Baltasar; N. Ratier-Werbin; C. Storfer; W. Sheu; S. Agarwal; M. Tamargo-Arizmendi; D.J. Schlegel; J. Aguilar; S. Ahlen; G. Aldering; S. Banka; S. BenZvi; D. Bianchi; A. Bolton; D. Brooks; A. Cikota; T. Claybaugh; A. de la Macorra; A. Dey; P. Doel; J. Edelstein; A. Filipp; J. E. Forero-Romero; E. Gazta ñaga; S. Gontcho A Gontcho; A. Gu; G. Gutierrez; K. Honscheid; E. Jullo; S. Juneau; R. Kehoe; D. Kirkby; T. Kisner; A. Kremin; K.J. Kwon; A. Lambert; M. Landriau; D. Lang; L. Le Guillou; J. Liu; A. Meisner; R. Miquel; J. Moustakas; A. D. Myers; S. Perlmutter; I. Pérez-Ràfols; F. Prada; G. Rossi; D. Rubin; E. Sanchez; M. Schubnell; Y. Shu; E. Silver; D. Sprayberry; N. Suzuki; G. Tarlé; B.A. Weaver; H. Zou
errShare
errSave
Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis
err2026-02-01
err0
PREAI
errRubin, David T.; Danese, Silvio; Nakase, Hiroshi; Ungaro, Ryan C.; Wolf, Douglas C.; Alekseeva, Olga; Petersen, AnnKatrin; Liu, Zhaohui; Mehra, Dimpy; Jain, Anjali; Osterman, Mark T.; Krakovich, Anthony; Riolo, Jon, V; DeBoer, Erik; Appio, James; Sinh, Preetika; Cree, Bruce A. C.; Cohen, Jeffrey A.; Irving, Peter
errShare
errSave
errShare
errSave
The Risk of Relapse Associated With Discontinuation of 5-Aminosalicylates in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
err2025-12-01
err0
PREAI
errArzivian, Arteen; Rubin, David T.; Seow, Cynthia H.; Kerkham, Alice; Tran, Yvonne; Leong, Rupert W.
errShare
errSave
Efficacy and Safety of Obefazimod in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two, Phase 3, Randomised, Double-Blind, Placebo-Controlled, 8-Week Induction Trials (ABTECT-1 and 2)
err2025-12-01
err0
PREAI
errSands, Bruce E.; Danese, Silvio; Peyrin-Biroulet, Laurent; Dubinsky, Marla; Hisamatsu, Tadakazu; Tilg, Herbert; Atreya, Raja; Armuzzi, Alessandro; Treton, Xavier; Baert, Filip; Seidler, Ursula; Cataldi, Fabio; Jacobstein, Doug; Rabbat, Christopher J.; Shan, Kejia; Duvall, George Aaron; Siegmund, Britta; Dulai, Parambir S.; Rubin, David; Vermeire, Severine
errShare
errSave
Guselkumab is Efficacious and Safe for Moderately-To-Severely Active Crohn's Disease: Real-World Data From a Large Tertiary Center
err2025-12-01
err0
PREAI
errShafrir, Asher; Mathew, Alex J.; Tanouye, Jessica T.; Hannett, Alexandra R.; Choi, David; Cohen, Russell D.; Rubin, David
errShare
errSave
High Burden of Extraintestinal Manifestations Following Diagnosis of Inflammatory Bowel Disease
err2025-12-01
err0
PREAI
errDubinsky, Marla; Haris, Golnoosh Alipour; Igho-Osagie, Ebuwa; Chandler, Paulette; Patel, Nilam; Rubin, David
errShare
errSave
Bowel Urgency and Fatigue in the Real-World are Correlated With Patient Reported Outcomes and Clinical Endpoints in Crohn's Disease
err2025-12-01
err0
PREAI
errDubinsky, Marla; Lewis, James; Rubin, David; Maria Chan, Wai Man; Vadhariya, Aisha; Zhou, Xian; Fisher, Deborah; Zhu, Baojin
errShare
errSave
Cutaneous and Genitalia Inflammation Treated With Guselkumab and Antimicrobial Therapy in a Patient with a History of Crohn's Disease
err2025-12-01
err0
PREAI
errNikzad, Newsha; Khadilkar, Surya; Onajin Darkwa, Oluwakemi; Mann Gradwohl, Kelsey; Chadha, Angad A.; Pekow, Joel; Rubin, David T.
errShare
errSave
Colonic Tissue Expression of MAdCAM-1 Is Not Predictive of Vedolizumab Responsiveness in Inflammatory Bowel Disease
err2025-11-24
err0
errOAAI
errReddy, Nikhil; Klein, Jeremy A.; Thomas, Nikita; Micic, Dejan; Deng, Zifeng; Rubin, David T.; Cohen, Russell D.; Dalal, Sushila; Christensen, Britt; Haider, Haider I.; Valuckaite, Vesta; Meckel, Katherine R.; Bissonnette, Marc; Weber, Christopher R.; Pekow, Joel
errShare
errSave
A positive Clostridioides difficile test does not impact outcomes in hospitalized patients with acute severe ulcerative colitis
err2025-11-21
err0
errOAAI
errGeethanjali Rajagopal; Raghavendra Paknikar; Zifeng Deng; Sujaata Dwadasi; Donald V. Goens; Maryam Zafer; Russell D. Cohen; Atsushi Sakuraba; David T. Rubin; Sushila Dalal; Dejan Micic; Joel Pekow
errShare
errSave